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G enetic testing, one tool in the armamen-tarium of the new molecular medicine, promises real benefits in humani ty 's ongoing war against sickness and prema-ture death. It seems likely that genetic 
technologies will, as is often claimed, "revolu-
tionize" clinical medicine. Genetic testing alone 
has made it possible lor physicians to: 
• Alter prenatal management 
• Provide more accurate diagnoses 
• Predict conditions before symptoms appear 
(e.g., Huntington's disease) 
• Identify predispositions to a variety of condi-
tions (e.g., colon cancer, Alzheimer's) 
• Tailor pharmaceuticals to individuals 
• Treat patients in utero 
These can be useful developments. Even so, 
the tact that the term "revolution" is used so fre-
quently in conjunction with them should give us 
pause. Although it sometimes has more benign 
connotations, "revolution" is fundamentally a 
political word, one suggesting force, violence, 
,\m\ power. It traditionally refers to the over-
throw of a regime, government, or social order.1 
The frequent conjunction of "genetics" and 
"revolution" is probably not accidental. One 
might argue that genetic testing also has a shad-
ow side, a "soft underbelly" wherein it finds itself 
in alliance with broader social agents, a tool by 
which those who shape society wield power. 
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To distinguish genetic testing's positive aspects 
from its downsides, we who work in Catholic 
health care must begin examining these new tech-
nologies in the light of our faith tradition. In this 
article, as a first step in creating such a theologi-
cal-moral critique, I identify: 
• four dimensions of genetic testing that belie 
its benevolent image 
• Three central Christian beliefs that are useful 
in assessing or challenging various assumptions 
and practices associated with genetic testing 
By bringing the latter to bear on the former, I 
hope to provide a model for how further theolog-
ical-moral critique might proceed. 
T H E " S O F T UNDERBELLY" 
To locate genetic testing under the rubric of 
"revolution," one would need to attend to the 
ways in which the practice functions as a means of 
power, how it contributes to the governance of 
individuals, and how it seeks to affect the social 
order. 
These dynamics are abundantly clear in hind-
sight when one views the history of genetics, 
which is the history of eugenics. Contemporary 
practices of genetics cannot be understood with-
out attention to the eugenic history that has 
shaped the discipline of molecular biology. Even 
the most cursory review of the history of eugenics 
reveals how it was used in the first half of the 
20th century, serving as, in Joanne Finkelstein's 
words, "a mode of applied sociology": a tool for 
the maintenance of a specific social order.2 
Garland Allen and Kenneth and Bettylee Garver 
provide a good overview of the eugenics move-
ment as it flourished in the United States during 
this period, identifying important socioeconomic 
and historical factors and some of the assump-
tions that guided the movement.' 
Eugenics is not simply a thing of the past. 
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Certain of its guiding assumptions remain alive. It 
is difficult to see them, however, immersed as we 
are in genetic technologies. Finkclstein suggests, 
moreover, that contemporary biomedicine— 
including genetic t e s t i n g -
exercises its power in a far 
more subtle and invidious 
fashion than eugenics did. 
Mow do the new genetic 
technologies give medicine -
and society through medicine— 
power over our lives? I would 
argue that they do so in four 
ways. 
Genetic Technologies Redefine Health 
and Disease With the molecular 
revolution, medical science 
ceased believing that disease is 
essentially caused by an exter-
nal agent—a pathogen or car-
c inogen, for example—and 
began searching for an internal 
agent instead. Consequently, 
as Finkclstein notes, "genetic 
flaws are being redefined into 
sites of medical intervention.''* 
Medicine, whether it perceives 
disease to be the cause of a single-gene disorder 
(because they reduce immunity to certain 
pathogens) or as part of the oncological pathway, 
now looks to genes as the source of disease and dis-
order. 
This relocating of the cause of disease changes 
the essential meaning of disease in at least three 
ways. First, one can now—in theory—have a dis-
ease but have no symptoms. Second, one can 
now be identified as having a disease before one is 
even born. Third, in an odd sort of way, one can 
"earn" a disease in one's body, never suffering a 
symptom oneself but always serving as the dis-
ease's potential transmitter. These are, of course, 
the presupposit ions behind presymptomatic 
genetic testing, prenatal genetic testing, and car-
rier testing. Diseases are no longer episodic 
events that arise, are treated, and cured. They 
have become essential parts of who we arc. 
Not only can one have a disease with no symp-
toms, one can also be diagnosed as possessing an 
as yet symptomless disease for which no treat-
ment exists. Indeed, for most of the conditions 
for which genetic testing can currently be done, 
rto therapies are available. Not that this is in itself 
new••; medicine has always lacked effective thera-
pies for at least some illnesses. But it used to be 
that, even if treatment for it were absent, the 
diagnosis of a disease provided both the symp-
tomatic patient and the physician with an answer 
.•* 
' " 
to a pressing problem—the presenting malady. 
Now, with genetic testing, the function of diag-
nosis and the labeling of disease states have 
become more ambiguous. 
A genetic definition of dis-
ease also exponentially in-
creases the range of possible 
diseases. Once the mapping 
work of the Human Genome 
Project is completed, the esti-
mated 30,000 genes in the 
human complement will, in 
theory, become sites for dis-
ease identification. 
Genetic Technologies Redefine 
Normality As more genes are 
identified and more locations 
for disease become available, 
more "ailments" may be "dis-
covered." Once one has a site 
upon which medical science 
can intervene, the temptation 
for medical science to do so 
increases. Trai ts tha t were 
previously considered "nor-
mal" tend to be reclassified as 
suitable for treatment. That 
which can be treated becomes, almost by defini-
tion, "pathological." 
In this dynamic process, moreover, normality 
and abnormality are no longer defined by the 
community at large, measured by the impact of 
the trait on communal life. Instead, they become 
defined by the biotech industry as it decides 
which conditions and disabilities will be located 
and remedied and which will be, if not remedied, 
stigmatized. By the same token, the pressures of 
genetic reductionism suggest that remedies for 
"abnormalities" need no longer be messy, com 
plicated, onerous social or behavioral practices. 
Now that such remedies are technological-genet 
ic in nature, they would seem to be far more effi-
cient, effective, and rational. Why should a prob-
lem drinker, for example, submit himself to 
Alcoholic Anonymous's extended discipline if 
gene therapy will do the trick instead? 
The standardization of genetic testing may 
subtly change the landscape of normality in 
another way. The search for innovative and effi-
cient approaches to genetic testing has recently 
led to the development not merely of multiplex 
testing—testing for more than one genetic variant 
through a particular assay—but of the "gene 
chip." A silicon analogue to the chips that power 
personal computers, the DNA chip gives biolo-
gists a way to assay potentially thousands of genes 
at one time. Now one's physician might find 
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"abnormalities" no one would have suspected. 
And because it measures his or her variation 
against the norm at an unprecedented number of 
data points, the test will also reveal a huge num-
ber of other bits of informat ion . Arc these 
"abnormalities''1? Are they medically significant? 
How is the poor patient to know ; 
Genetic Technologies Diminish Individual Autonomy Once 
the gene has been defined as the disease's locus, 
and once a large number of disease sites have 
been identified, it will be only natural for the 
biotech industry to develop medications and 
treatments for them. The internal logic of genetic 
technology promises an increased "medicaliza-
tion" of human life. This trend threatens to seri-
ously diminish individual freedom and autonomy. 
We know, of course, that misuse of genetic 
information in the realms of employment, educa-
tion, or insurance is a danger. Hut Finkelstein 
suggests a more subtle and ironic threat to free-
dom: the way genetic testing can increase the 
dependence of individuals upon the medical pro-
fession/ The mere availability of tests for hun-
dreds of genes will encourage in increased medi-
cal surveillance of the individual body. As more-
tests become available and DNA chip technology 
is perfected, medical specialists will have access to 
AV\ infinitely greater range of information. To test 
for one condition will be to test for them all. 
What would informed consent for such testing 
mean in this situation? As the human genome is 
mapped, more diseases are discovered, and more 
treatments for these diseases are developed, indi-
vidual lives themselves become increasingly 
mapped by medicine. The logic that drives genet-
ic technology seeks to bring more and more of 
human life—in all its aspects, nonmedical as well 
as medical—into medicine's domain. 
Will patients want such tests? Some clearly will. 
Some will desire information relevant to their 
immediate medical concerns. Others may be 
tempted with the promise of self-knowledge. But 
even if genetic tests are administered in response 
to patient desires, Finkelstein, tor one, questions 
the nature of the apparent autonomy involved. 
For, she notes, in a technologically mediated 
society, interests, values, and desires are often 
cultivated by those who control the technology. 
More often than not, those who control the tech-
nology are motivated by a desire for profit." 
As we have seen repeatedly, especially over the 
past live years or so, biotechnological research is 
often initially justified by therapeutic rhetoric 
(children with diseases often figure prominently 
in such appeals). Cloning, it was argued, would 
provide a much-needed resource for the produc-



















Gene "therapy," it was argued, would provide 
much-needed cures for tragic single-gene disor-
ders that caused significant childhood suffering 
and early death. Sperm separation and selection 
technology was developed to prevent X-linked 
genetic diseases. Once researchers achieve the 
necessary technological breakthroughs, however, 
the focus of application tends to change. No 
longer are the technologies restricted to a thera-
peutic context; often, in fact, their therapeutic 
aspirations remain unrealized. Instead, the tech-
nologies are made available (at least in theory) for 
any application desired by the market. Thus 
researchers in New York announced last fall a 
possible gene " the rapy" for baldness , and 
Microsort is made available to couples who sim-
plv wish to select the gender of their children. 
Once technologies are available, applications 
must be found—and it is the job of the biotech 
company to cultivate in the general public a desire 
for whatever outcomes such technologies can 
achieve. Over time, as with ultrasound anil amnio-
centesis, certain technological interventions 
become standard components in medical ca re -
even if they provide no significant medical benefit. 
In this way, individuals may find themselves 
coopted into submitting to technology that does 
not necessarily serve their interests. The practice of 
prenatal genetic testing is a case in point. As two 
students of the procedure have observed, "The 
majority of current genetic testing is geared to 
counseling for reproductive or prenatal decisions."" 
Note that prenatal diagnosis is not conducted to 
design therapies for the fetus, the child-to-be. As 
for prenatal counseling, couples who choose to be 
tested may in tact find themselves in a traumatic sit 
uation—as when, for example, they learn that the 
fetus has certain anomalies and they must decide 
what to do about it. Such "freedom" has large 
implications. The termination of one genetically 
defective fetus does not a eugenics movement 
make, but each act, when multiplied by thousands 
or millions, translates into a significant social 
impact. As for client autonomy, are not the deci-
sions in such cases at least partly shaped by the 
practitioner who does the testing? 
Genetic Technologies Promote a Vision of Utopia Behind 
genetic testing is a vision—a vision, as Finkelstein 
calls it, of "bio-utopia."8 Each new development 
and discovery promises an end to disease as we 
know it (listen, for example, to the rhetoric sur-
rounding gene therapy and human embryonic 
stem cells), as well as limitless human enhance-
ment. Genetic testing is seen as a vital first step 
toward a kind of Holy Grail. Medicine, through 
genetic and allied technologies, promises the per-
fection of human life. 
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This is, of course, an eschatological vision, a 
vision of what the world will be like when the sav-
ior—medicine, in this case—comes into its own. 
Once one starts discussing eschatology, however, 
one leaves the realm of medicine and moves into 
the realm of theology. 
THEOLOGICAL SOURCES OF RESISTANCE 
If the genetic turn in medicine is indeed a revolu-
tion, if it entails a new exercise of power and is 
grounded in a particular eschatological vision, 
how should Cathol ic medical pract i t ioners 
respond to it? Ought they simply profess loyalty 
to the new regime and accept practices that con-
solidate the new power? Or is the question more 
complex? Is resistance in order, at least to some 
degree? And, if it is in order, from whence might 
such resistance arise? 
Catholics—and Christians generally—know 
themselves to be citizens of a different regime, 
namely, the church. Here, within the Christian 
theological tradition, practitioners and patients 
might find resources for a more nuanced and 
careful appropriation of the practice of genetic 
testing. Three convictions central to the Catholic 
tradition provide some critical purchase on these 
questions. 
A Traditional Commitment to Healing Catholic thinking 
about any aspect of health care ought to begin 
with one of Jesus' primary activities: healing. The 
Ethical and Relijjious Directives for Catholic 
Health Care Services emphasizes the ccntrality of 
healing for a Catholic approach to health care; its 
very first sentences say, "The Church has always 
sought to embody our Savior's concern for the 
sick. The gospel accounts of Jesus' ministry draw 
special attention to his acts of healing. . . . In 
faithful imitation of Jesus Christ, the Church has 
served the sick, suffering, and dying in various 
ways throughout history."" 
God (the tradition attests) affirms life, well-
ness, wholeness, and embodied flourishing. 
Medicine and its various technologies are rightly 
seen as elements of God's good creation, agents 
of God's healing. Those who practice the art of 
medicine should see themselves as ministers of 
God's grace and presence. 
This commitment to healing provides us with 
substantive guidance for understanding the tech-
nology of genetic testing. In cases where genetic 
testing aids critical medical diagnosis and furthers 
therapeutic intervention, it is clearly a legitimate 
medical tool. Its use ought to be encouraged in 
the following sorts of situations: 
• Diagnosing a presenting illness to determine 
the proper course of treatment for it 
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colon cancer) in which early detection could be 
beneficial and effective treatment is available 
• Carrier testing in counseling a couple at risk 
for transmitting a serious congenital illness (e.g., 
Tay-Sachs disease) accompanied by significant 
suffering and early mortality 
Genetic testing in such situations furthers the 
end of healing. In others, however, its healing 
dimension is more dubious. One can clearly won-
der whether the tools of medicine should be used 
for nonmedical purposes—employment testing, 
for example. What about tests designed to diag-
nose conditions for which no effective therapy 
exists? Of what medical use is it (aside from 
deciding whether to have children) to learn that 
one will someday be stricken with Huntington's 
or Alzheimer's? How could such knowledge be 
described as "healing"? 
The Christian commitment to healing should 
also inspire questions concerning testing practices 
that simply increase the medicalization of human 
life. Such practices include: 
• Testing for conditions for which patients are 
not at risk and for which no symptoms are pre-
senting, especially multiplex testing 
• Testing for a condition that does not signifi-
cantly affect the patient's physical well-being but 
tor which a putative treatment exists 
Medicalization—which enlarges disease's role 
in the life of the person—is antithetical to a vision 
of healing. It is also antithetical to the Christian 
commitment to responsible stewardship of health 
care resources . In the Chris t ian t r ad i t ion , 
medicine is not a consumer commodity supplied 
to patients simply because they desire its power. 
Medicine is (or ought to be) a tool of healing, a 
service to the sick, suffering, and dying. 
The Image of a Trinitarian God As Rev. Benedict 
Ashley, OP, and Rev. Kevin O'Rourke, OP, have 
said so well, "The basic principle of healthcare 
ethics is the dignity of the human person. . . . 
The goal of healthcare is to contribute to the full 
development of human persons. . . . Healthcare 
tails whenever it tends to depersonalize its clients 
by ignoring or restricting this freedom."1" Such a 
claim may seem on the surface rather formal, but 
Ashley and O'Rourke make it clear that the terms 
"dignity" and "full development," as they use 
them, are informed by a specific tradition rich 
with meaning. 
A theological understanding of the dignity of 
the human person begins with a general recogni-
tion of the goodness of God's creation. We, along 
with all other living things, were called into being 
by God and are sustained by God 's gracious 
goodness. As such, we are to be celebrated, nour-
ished, and helped to flourish to the fullest extent 
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possible. What is more, the tradition affirms from 
the beginning that humans have the added grace 
of being created in the image and likeness of 
God." This is a rich metaphor, thick with multiple 
meanings (creator, servant, sufferer, redeemer), 
pointing us tow aid that which we are called to be. 
The fact that humans are created in the image 
of God points to the essence of God's nature, 
captured in the mystery of the Trinity. The Trinity 
is certainly a complex metaphor (not to mention a 
mystery) , but also one that has been richly 
explored in the tradition. In the early church, 
Augustine's De Trinitate was the most influential 
explanation of the doct r ine of the Trini ty. 
Augustine, who interpreted the Trinity through 
the theological claim that God is love, described it 
as the dynamic interchange that exists between a 
lover, the beloved, and the love they share. 
This image points to one fundamental signifi-
cance of the doctrine of the Trinity, namely, the rev-
elation that God's nature, the Very essence of God is 
relational. God is not monolithic. God's essential 
reality is a community of persons, who, as love, live 
in perpetual self-giving and self-receiving.13 A consti-
tutive member of the Trinity is, moreover, the Son, 
the subject not only of the Incarnation and 
Resurrection but also of the Passion. The Son suf-
fered. The experience of suffering is intrinsic to the 
very identity and being of the Trinity. 
How might such a vision of the Trinity speak 
to genetic testing as a technology practiced upon 
persons created in a Trinitarian image and like 
ness? It would celebrate genetic testing insofar as 
it contributes to human flourishing, especially by 
preventing disease and promoting healing. In 
tact, the vision would remind practitioners that 
people flourish most fully when they are liberated 
from medical care—when they are well. By the 
same token, the vision would critique those 
genetic testing practices that decrease human 
freedom by increasing dependence on medicine. 
(When, for example, genetic testing confuses dis-
ease with identity, or multiplies interventions for 
trivial conditions, or increases medical surveil-
lance of the body, it puts human beings into a 
kind of bondage to medicine.) And the vision of 
the Trinity would critique genetic testing that, on 
one hand, manipulates patients' desires in the 
interest of profit or social control, while, on the 
other hand* it promotes the myth that those 
patients are making autonomous choices. 
But threats to freedom are not the only ways in 
which genetic testing may undercut human digni-
ty .md flourishing. Eugenic applications of prena-
tal genetic testing directly deny the goodness of 
God's creation and contribute in no way to the 
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fully, the trinitarian tradition affirms, as their con-
nectedness in community and their network of 
relationships increases. That being the case, uses 
of genetic tests that handicap persons socially by 
stigmatizing them as intrinsically "abnormal" will 
obstruct their full development. Finally, the tradi-
tion affirms that suffering, though not to be 
sought out, is both a part of the human condition 
and theologically charged. As the Ethical ana" 
Relijjious Directives note: 
For the Ghristian, our encounter with suf-
fering and death can take on a positive and 
distinctive meaning through the redemp-
tive power of Jesus' suffering and death. As 
St. Paul says, we are "always carrying about 
in the body the dying of Jesus, so that the 
life of Jesus may also be manifested in our 
body" (2 Cor 4:10). This truth does not 
lessen the pain and fear, but gives confi-
dence and grace for bearing suffering rather 
than being overwhelmed by it. Catholic 
health care ministry bears witness to the 
truth that, for those who are in Christ, suf-
fering and death are the pangs of a new cre-
ation. "God himself will always be with 
them . . .»" 
An Alternative Eschatology This refusal to shy away 
from the reality of suffering and abandon those 
who suffer from genetic conditions brings us to 
our last point. Genetic technologies, as noted 
above, presume an eschatological vision. A differ-
ent eschatological vision underpins the whole of 
the Christian tradition. The Catholic author 
Flannery O'Connor captures this vision in her 
characteristically startling fashion in her short 
story "Revelation," a story that, interestingly 
enough, begins in a physician's office. Near the 
end of the story, the major character, Mrs. 
Tuipin, experiences a vision: 
There was only a purple streak in the sky, 
cutting through a field of crimson and lead-
ing, like an extension of the highway, into 
the descending dusk. She raised her hands 
from the side of the [pig] pen in a gesture 
hieratic and profound. A visionary light set-
tled in her eyes. She saw the streak as a vast 
swinging bridge extending upward from 
the earth through a field of living fire. 
Upon it a vast horde of souls were rum-
bling toward heaven. There were whole 
companies of white-trash, clean for the first 
time in their lives, ^nd bands of black[s] in 
white robes . . . and battalions of freaks and 
lunatics. . . . And bringing up the end of 
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the procession was a tribe of people whom 
she recognized at once as those who, like 
herself and Claud, had always had a little of 
everything and the God-given wit to use it 
right. She leaned forward to observe them 
closer. They were marching behind the 
others with great dignity, accountable as 
they had always been for good order and 
common sense and respectable behavior. 
They alone were on key. Yet she could see 
by their shocked and altered faces that even 
their virtues were being burned away." 
O'Connor, herself a victim of the debilitating 
disease lupus, is here echoing the biblical vision of 
the Eucharistic i\iu\ eschatological banquet found, 
among other places, in the Gospel of Luke.1" (This 
banquet is also invoked in the conclusion of the 
Ethical ami Religions Directives.) Note the differ-
ence between Christian eschatology and secular 
eschatology. Unlike the secular vision, the 
Christian vision includes impaired people in its 
number: freaks, lunatics, the maimed, the blind, 
and the lame. In tact, as O'Connor shows, in the 
Christian vision these figures become central. In 
the Gospel, those who are healthy, prosperous, 
and socially successful—by all standards "perfect"— 
refuse to come to the banquet. They exclude 
themselves. O'Connor's vision adds ^\n interesting 
twist: Here the healthy and socially secure are in 
the procession, but their perfections—"even their 
virtues," as she puts it—are being "burned away." 
O'Connor's immersion in the Catholic tradition 
informs her understanding that our pretensions to 
perfection, especially our "natural" virtues, are, in 
eschatological terms, vices. 
A practice of genetic testing that promotes 
healing and the dignity of the human person 
should be celebrated as a ministry of discipleship 
and a creation of God's goodness. Insofar as such 
a practice sees itself as promoting a secular escha-
tology, however, it will find itself at odds with the 
meaning and purpose of Catholic health care. 
Practitioners and patients grounded in Christian 
eschatology will remember that the agent of 
human perfection is God, not genetics, and will 
recognize the genetically impaired as the privi-
leged guests at the banquet. The Christian escha-
tological vision is a political vision—a vision of the 
Kingdom. We, confronted by the genetic revolu-
tion, must decide which of the two regimes will 
have dominion over our lives. o 
/ would like to thank Ron Hamel ami the planning com-
mittee of C'HA's 14th Annual Invitational Theology and 
Ethics Colloquium for providing me with the opportunity 
to prepare these remarks. 
N O T E S 
A practice of 
genetic testing 
that promotes 
healing and the 
dignity of the 
human person 
should be 
celebrated as a 
ministry of 
discipleship and 
a creation of 
God's 
goodness. 
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